Snezhana Rusinova-Videva | Biotechnology | Best Research Article Award

Posted on 30/10/202430/10/2024 by Pencis

Snezhana Rusinova-Videva | Biotechnology | Best Research Article Award

Dr. Snezhana Rusinova-Videva, The Stephan Angeloff Institute of Microbiology-BAS, Bulgaria.

Dr. Snezhana Rusinova-Videva is a distinguished researcher in Biotechnology, recognized for her contributions to advancing scientific knowledge in this field. With a focus on innovative biotechnological applications, Dr. Rusinova-Videva has earned significant accolades for her groundbreaking research, which has had a substantial impact on both academic and industrial biotechnology. She holds a doctoral degree in Biotechnology and has authored numerous peer-reviewed articles that explore sustainable solutions in bioengineering and bioprocess optimization. Her dedication to high-quality research and her commitment to fostering scientific innovation have led to her recent recognition with the Best Research Article Award.

Profile:

Scopus Profile

Google Scholar Profile

Education and Training

Dr. Snezhana Rusinova-Videva pursued her Ph.D. at The Stephan Angeloff Institute of Microbiology, part of the Bulgarian Academy of Sciences in Sofia, Bulgaria, from 2008 to 2013. She holds a Master’s degree in Microbial Biotechnology, awarded in 2007 by Plovdiv University “Paisii Hilendarski,” where she also completed her Bachelor’s degree in Biology and Chemistry in 2005.

Experience

Dr. Snezhana Rusinova-Videva has been a Senior Assistant Professor in Microbiology at The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences in Sofia, Bulgaria, since 2014. Prior to this role, she served as an Assistant Professor from 2012 to 2014 at the same institute, with additional work conducted in Plovdiv. Her research and teaching focus on advancing microbiological studies within the Bulgarian Academy of Sciences, where she continues to contribute her expertise in the field.

Courses

Dr. Snezhana Rusinova-Videva is a dedicated academic and researcher who was actively involved in the Faculty of Biology at Plovdiv University “Paisii Hilendarski” from 2014 to 2018. During this time, she delivered both lecture and exercise courses across multiple subjects. She led a lecture course in Mycology at the university’s Kardzhali branch from 2016 to 2018. Simultaneously, she conducted exercise courses in Mycology and Hydrobiology at the main faculty from 2014 to 2018, along with an exercise course in Plant Ecology in the 2014-2015 academic year. Her dedication to scientific collaboration is also evident in her role as a member of the Organizing Committee for the International Conference on the Rational Use of Natural Products, held in 2013, 2015, and 2017, which brought together participants from over 50 countries.

Top Note Publications

Title: Rosehip Seed Oil-Incorporated Chitosan Films for Potential Fruit Packaging Applications

Authors: Marudova, M., Zsivanovits, G., Viraneva, A., Gechev, B., Rusinova-Videva, S.
Year: 2024
Citations: 0

Title: Analysis of Wild Edible Mushrooms in the Regions Strandzha and the Black Sea Coast in Bulgaria

Authors: Radoukova, T., Stoyanov, P., Mladenova, T., Todorov, K., Rusinova-Videva, S.
Year: 2024
Citations: 0

Title: Biosynthetic capabilities of Antarctic yeast Sporobolomyces roseus AL103: Temperature influence on intracellular metabolites and characterization of the exopolysaccharide

Authors: Rusinova-Videva, S., Ognyanov, M., Alipieva, K., Paunova-Krasteva, T., Mateev, D.
Year: 2024
Citations: 0

Title: Extremophiles as a “green source” of new exopolysaccharides with ecological importance and multifunctional applications

Authors: Radchenkova, N., Rusinova-Videva, S.
Year: 2024
Citations: 2

Title: Chemical characterization and biological effect of exopolysaccharides synthesized by Antarctic yeasts Cystobasidium ongulense AL101 and Leucosporidium yakuticum AL102 on murine innate immune cells

Authors: Rusinova-Videva, S., Ognyanov, M., Georgiev, Y., Dimitrova, P., Kambourova, M.
Year: 2023
Citations: 7

Yi HSin Wang | Antibiotic | Best Researcher Award

Posted on 28/10/202428/10/2024 by Pencis

Yi HSin Wang | Antibiotic | Best Researcher Award

Assist Prof Dr. Yi HSin Wang , Chung Shan Medical University, Taiwan.

Assist Prof Dr. Yi Hsin Wang is a dedicated researcher specializing in antibiotic discovery and development. With a strong academic foundation in microbiology and pharmacology, she has contributed significantly to the understanding of antibiotic resistance mechanisms and the identification of novel antimicrobial agents. Her work focuses on developing innovative strategies to combat bacterial infections, making a profound impact on public health. Yi Hsin has published numerous articles in peer-reviewed journals and has presented her research at international conferences, showcasing her commitment to advancing the field of antibiotic research. Her dedication to scientific excellence and her contributions to antibiotic development make her a deserving candidate for the Best Researcher Award.

Profile:

Scopus Profile

Education

Assist Prof Dr. Yi-Hsin Wang pursued his academic journey at Chung Shan Medical University, beginning with a Bachelor of Science degree in Medical Applied Chemistry from 2008 to 2012. He then advanced to the Institute of Medicine at the same university, completing a Master of Science degree from 2012 to 2014 under the guidance of Professors Jinghua Tsai Chang and Shiang-Suo Huang. Building upon his research foundation, Yi-Hsin continued his studies in the Institute of Medicine, where he earned his Ph.D. from 2014 to 2018, with Professors Jinghua Tsai Chang and Shiang-Suo Huang as his advisors once again.

Experience

Assist Prof Dr. Yi-Hsin Wang currently holds the position of Assistant Professor in the Department of Physiology at Chung Shan Medical University’s School of Medicine (2022.08–present). Previously, Wang served as a Postdoctoral Researcher in the Department of Pharmacology at China Shan Medical University’s School of Medicine (2019.08–2022.07) and in the Graduate Institute of Acupuncture Science at China Medical University (2018.09–2019.07), with a strong focus on physiology, pharmacology, and acupuncture science throughout their academic and research career.

Skills

Assist Prof Dr. Yi-Hsin Wang possesses a range of experimental skills, including expertise in creating animal models for myocardial infarction and ischemic stroke. Additionally, Wang is proficient in Western blotting, gelatin zymography, and immunohistochemistry, each essential for analyzing protein expression, enzyme activity, and tissue-specific antigen localization.

Awards

Assist Prof Dr. Yi-Hsin Wang has received notable awards for contributions to biomedical sciences, including the Young Scientist Travel Award at the 9th FAOPS Congress (2019) in Japan and 2nd place in the Poster Award at the 33rd Joint Annual Conference of Biomedical Sciences (2018) in Taiwan.

Research Skills

Assist Prof Dr. Yi-Hsin Wang research expertise encompasses a diverse range of fields, including cardiology, with a focus on cardioprotection, and extends to neuroscience, particularly in the area of neuroprotection. His work also addresses the mechanisms underlying ischemia/reperfusion injury, contributing to a deeper understanding of both brain and cardiovascular physiology.

Top Note Publications

Title: Dunaliella salina Alga Protects against Myocardial Ischemia/Reperfusion Injury by Attenuating TLR4 Signaling

Authors: Tsai, C.-F., Lin, H.-W., Liao, J.-M., … Wang, M., Huang, S.-S.
Year: 2023
Citations: 4

Title: Lumbrokinase Regulates Endoplasmic Reticulum Stress to Improve Neurological Deficits in Ischemic Stroke

Authors: Wang, Y.-H., Liao, J.-M., Chen, K.-M., … Tsai, C.-F., Huang, S.-S.
Year: 2022
Citations: 5

Title: Activation of Peripheral TRPM8 Mitigates Ischemic Stroke by Topically Applied Menthol

Authors: Huang, S.-S., Su, H.-H., Chien, S.-Y., … Lee, H.-H., Chen, Y.-H.
Year: 2022
Citations: 14

Title: In Situ Slow-Release Recombinant Growth Differentiation Factor 11 Exhibits Therapeutic Efficacy in Ischemic Stroke

Authors: Su, H.-H., Yen, J.-C., Liao, J.-M., … Chen, Y.-H., Huang, S.-S.
Year: 2021
Citations: 5

Title: Paeonol Protects Against Myocardial Ischemia/Reperfusion-Induced Injury by Mediating Apoptosis and Autophagy Crosstalk

Authors: Tsai, C.-F., Su, H.-H., Chen, K., … Wang, Y.-H., Huang, S.-S.
Year: 2021
Citations: 27

Serge Poda | Malaria | Best Researcher Award

Posted on 26/10/202428/10/2024 by Pencis

Dr. Serge Poda | Malaria | Best Researcher Award

Dr. Serge Poda, Institut de Recherche en Sciences de la Santé, Burkina Faso.

Dr. Serge Poda, a distinguished malaria researcher, has dedicated his career to studying malaria transmission dynamics and effective control strategies, particularly in endemic regions across Africa. His impactful research focuses on identifying transmission hotspots, assessing antimalarial drug efficacy, and advancing vector control measures. With numerous peer-reviewed publications and collaborations with global health organizations, Dr. Poda’s work continues to shape malaria eradication efforts and improve public health policies worldwide. Recognized with the Best Researcher Award, Dr. Poda’s contributions are invaluable to the fight against malaria and improving healthcare outcomes in vulnerable communities.

Profile:

Scopus Profile

Orcid Profile

Google Scholar Profile

Education

Dr. Serge Poda earned his Ph.D. in Applied Biological Sciences with a focus on Medical Entomology in 2021 from the University Joseph KI-ZERBO (formerly University of Ouagadougou) in Burkina Faso. He holds a Master’s degree in Microbial and Cellular Biotechnology (2014) and a Bachelor’s degree in Fundamental and Applied Biology, specializing in Biochemistry and Microbiology (2011). Dr. Poda’s academic foundation was built upon his Baccalaureate in Natural Sciences, Mathematics, Physics, and Chemistry (2007), equipping him with the multidisciplinary expertise essential for his research in malaria and disease prevention.

Experience

Dr. Serge Poda is currently a Postdoctoral Fellow at Wageningen University & Research in the Netherlands, where he investigates in-flight mating behaviors in sympatric swarms of Anopheles malaria mosquitoes and their hybrids. Previously, as a Ph.D. student (2017–2021) at IRSS (Burkina Faso), MIVEGEC-IRD, and CNRS (France), he researched long-range chemical and visual cues used by Anopheles females to locate male swarms. His postgraduate fellowship at IRSS (2014–2017) focused on how irradiation impacts the reproductive success and vector competence of An. arabiensis. For his Master’s thesis (2013–2014), Dr. Poda evaluated the effectiveness of insecticide-treated paint against pyrethroid-resistant malaria vectors in Burkina Faso. Additionally, his graduate internship (2012–2013) at IRSS allowed him to develop essential skills in malaria and dengue entomological techniques, laying a strong foundation for his career in medical entomology.

Skills

Dr. Serge Poda possesses a range of skills that support his expertise in malaria research. He is fluent in French and has an intermediate command of English. Proficient in data analysis tools like R and GenePop, he also utilizes Trackit 3D for video tracking and recording. His technical abilities include designing bioassays for insecticide and behavioral testing, rearing mosquitoes, conducting mosquito swarm studies, and performing field, semi-field, and laboratory research. Additionally, Dr. Poda is skilled in molecular techniques such as PCR and ELISA, as well as in Volatile Organic Compound extraction, GC-MS and GC-EAG analyses, and 3D trajectory recording and analysis.

Grands and Scholarships

Dr. Serge Poda has been awarded several prestigious grants and scholarships throughout his career. As Principal Investigator of the Africa Talent Programme grant from Wageningen University & Research (€291k, 2022–2025), he secured funding for a postdoctoral fellowship to study in-flight mating behaviors in sympatric swarms of Anopheles mosquitoes and their hybrids. He also served as Co-Investigator for the LAMIVECT grant (€3k, 2020), a micro-project aimed at developing diets with local ingredients to optimize Aedes and Anopheles mosquito production for genetic control research. Dr. Poda’s scholarships include the UEMOA Excellence Scholarship (2019–2020), awarded for his exceptional academic achievements, the ARTS Ph.D. Scholarship from the French National Research Institute for Sustainable Development (IRD, 2017–2020), and the Burkina Faso government Ph.D. scholarship (2017–2021), both of which supported his doctoral studie

Top Note Publications

Title: Mosquitoes integrate visual and acoustic cues to mediate conspecific interactions in swarms

Authors: Gupta, S., Cribellier, A., Poda, S.B., Muijres, F.T., Riffell, J.A.
Journal: Current Biology
Year: 2024

Title: Adult mosquito predation and potential impact on the sterile insect technique

Authors: Bimbilé Somda, N.S., Maïga, H., Mamai, W., Yamada, H., Bouyer, J.
Journal: Scientific Reports
Year: 2022

**Title: Local adaptation and colonization are potential factors affecting sexual competitiveness and mating choice in Anopheles coluzzii populations**

Authors: Nignan, C., Poda, B.S., Sawadogo, S.P., Roux, O., Diabaté, A.
Journal: Scientific Reports
Year: 2022

Title: No evidence for long-range male sex pheromones in two malaria mosquitoes

Authors: Poda, S.B., Buatois, B., Lapeyre, B., Dabiré, R.K., Roux, O.
Journal: Nature Ecology and Evolution
Year: 2022

Title: Malaria vectors diversity, insecticide resistance and transmission during the rainy season in peri-urban villages of south-western Burkina Faso

Authors: Soma, D.D., Poda, S.B., Hien, A.S., Moiroux, N., Dabiré, R.K.
Journal: Malaria Journal
Year: 2021

Serena Vita | Arbovirosi | Women Researcher Award

Posted on 22/10/202422/10/2024 by Pencis

Serena Vita | Arbovirosi | Women Researcher Award

Dr. Serena Vita , Istituto Nazionale di Malattie Infettive, Lazzaro Spallanzani, Italy.

Serena Vita is an accomplished researcher specializing in arbovirosis, focusing on viral diseases transmitted by mosquitoes, such as dengue, Zika, and chikungunya. Her innovative work in epidemiology, vector control, and public health strategies has significantly contributed to the prevention and management of arboviral diseases, particularly in tropical regions. Recognized for her groundbreaking research, Dr. Vita has received the Women Researcher Award, honoring her leadership in the field of infectious diseases and her dedication to advancing global health initiatives.

Profile:

Scopus Profile

Education and Training

Dr. Serena Vita holds a robust academic background in infectious diseases. She earned an MSc in Antibiotic Stewardship from the Catholic University of Rome in 2021, focusing on infectious diseases and hospital infections. Prior to this, she completed an MSc in Sepsis and Surgery (2013-2014) from the same university, specializing in hospital infections and surgical infections. Dr. Vita obtained her PhD in Infectivological Science and Immunological Therapies from the University of Rome Sapienza (2009-2013), where her research focused on T cell phenotypes during chronic CMV infection. Earlier, she completed an Infectious Disease Training Course at the same institution (2005-2009), graduating cum laude with a thesis on meningoencephalitis in pediatric cases.

Experience

Dr. Serena Vita has extensive experience in the field of infectious diseases, currently serving as an Infectious Disease Consultant at the National Institute for Infectious Diseases (INMI) IRCCS L. Spallanzani in Rome, where she focuses on both clinical care and research. From 2017 to 2019, she worked at Santa Maria Goretti Hospital in Latina, coordinating clinical, research, and training programs on HIV and CMV infections in adults and pregnant women. Prior to that, she was a Research Fellow at Sapienza University of Rome, leading a project on HCV-related hepatopathy and CMV co-infection. Between 2014 and 2017, she worked as a Post-Doctoral Researcher at the Infectious Disease Italian Society, conducting research on immune responses in chronic CMV infection in HIV patients. Earlier in her career, she was a Post-Doctoral Researcher at the Pasteur Institute, studying the impact of CMV infection on immune markers in HIV-infected individuals. From 2012 to 2017, she also served as an Infectious Disease Consultant at AUXILIUM, providing healthcare and treatment for migrant populations.

Field of Interest

Dr. Serena Vita’s principal areas of expertise lie in the clinical management of emerging and reemerging infectious diseases, including COVID-19. She has a strong interest in the immunology of infectious diseases, focusing on the intricate host-pathogen interactions. Additionally, she is deeply committed to improving migrant health, ensuring that vulnerable populations receive appropriate care and attention in the context of infectious disease outbreaks.

Academic Activities

Dr. Serena Vita has been actively involved in academic activities, serving as a Teaching Assistant for the Infectious Diseases course (2015–2018) in both the Italian (“C”) and English (“F”) degree programs in Medicine and Dentistry at Sapienza University of Rome, under the direction of Prof. M.R. Ciardi. Between 2013 and 2017, she tutored PhD students in Infectious Disease Sciences and Immunological Therapies, working with Prof. Vincenzo Vullo in the Infectious Diseases laboratory, where she supervised PhD theses on HIV, HCV, HIV/HCV co-infection, and Tuberculosis. Her work included training in techniques like PBMC isolation, lymphocyte stimulation, and flow cytometry. Additionally, in 2012, she contributed to the Second Level Master’s program in Clinical Neuroimmunology at Sapienza University, coordinated by Prof. Ada Francia. Earlier in her career, from 2006 to 2010, she lectured on Infectious and Tropical Diseases in the elective module of Integrated Pathology V for the Degree Course in Medicine and Surgery at Sapienza University.

Top Note Publications

Antinori, A., Mazzotta, V., Vita, S.*, Carletti, F., Tacconi, D., Lapini, L. E., D’Abramo, A., Cicalini, S., Lapa, D., Pittalis, S., Puro, V., Rivano Capparuccia, M., Giombini, E., Gruber, C. E. M., Garbuglia, A. R., Marani, A., Vairo, F., Girardi, E., … Vaia, F. (2022). Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022. Eurosurveillance, 27(22), 2200421. https://doi.org/10.2807/1560-7917.es.2022.27.22.2200421.
Impact Factor: 19, Citations: 398 (*corresponding author).

D’Abramo, A., Vita, S., Maffongelli, G., Mariano, A., Agrati, C., Castilletti, C., Goletti, D., Ippolito, G., & Nicastri, E. (2021). Prolonged and severe SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: A tailored approach. International Journal of Infectious Diseases, 107, 247–250. https://doi.org/10.1016/j.ijid.2021.04.068.
Impact Factor: 12.7, Citations: 36.

D’Abramo*, A., Vita*, S., Maffongelli, G., Beccacece, A., Agrati, C., Cimini, E., Colavita, F., Giancola, M. L., Cavasio, A., & Nicastri, E. (2022). Clinical management of patients with B-cell depletion agents to treat or prevent prolonged and severe SARS-CoV-2 infection: Defining a treatment pathway. Frontiers in Immunology, 13, 911339. https://doi.org/10.3389/fimmu.2022.911339.
Impact Factor: 7.3, Citations: 16 (*both first authors).

Vita, S., Di Bari, V., Corpolongo, A., Goletti, D., Espinosa, J., Petracca, S., Palmieri, F., Nicastri, E., Abbonizio, Agrati, C., … Valli, M. B. (2021). Down syndrome patients with COVID-19 pneumonia: A high-risk category for unfavorable outcome. International Journal of Infectious Diseases, 103, 607–610. https://doi.org/10.1016/j.ijid.2020.11.188.
Impact Factor: 12.7, Citations: 12.

Vita, S., Rosati, S., Ascoli Bartoli, T., Beccacece, A., D’Abramo, A., Mariano, A., Scorzolini, L., Goletti, D., & Nicastri, E. (2022). Monoclonal antibodies for pre- and postexposure prophylaxis of COVID-19: Review of the literature. Pathogens, 11(8), 882. https://doi.org/10.3390/pathogens11080882.
Impact Factor: 3.7, Citations: 13.

Vita, S., D’Abramo, A., Coppola, A., Farroni, C., Iori, A. P., Faraglia, F., Sette, A., Grifoni, A., Lindestam Arlehamn, C., Bibas, M., … Nicastri, E. (2024). Combined antiviral therapy as an effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-CoV-2 infection: A case report. Frontiers in Oncology, 14, 1290614. https://doi.org/10.3389/fonc.2024.1290614.
Impact Factor: 3.5, Citations: 4.

Vita, S., Bordi, L., Sberna, G., Caputi, P., Lapa, D., Corpolongo, A., Mija, C., D’Abramo, A., Maggi, F., Vairo, F., … Nicastri, E. (2024). Autochthonous dengue fever in 2 patients, Rome, Italy. Emerging Infectious Diseases, 30(1). https://doi.org/10.3201/eid3001.231508.
Impact Factor: 7.2, Citations: 1.

Farroni, C., Aiello, A., Picchianti-Diamanti, A., Laganà, B., Petruccioli, E., Agrati, C., Garbuglia, A. R., Meschi, S., Lapa, D., Cuzzi, G., … Vita, S., … Goletti, D. (2022). Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study. International Journal of Infectious Diseases, 125, 195–208. https://doi.org/10.1016/j.ijid.2022.10.035.
Impact Factor: 8.4, Citations: 24.

Mondi, A., Lorenzini, P., Castilletti, C., Gagliardini, R., Lalle, E., Corpolongo, A., Valli, M. B., Taglietti, F., Cicalini, S., Loiacono, L., … Zito, S. (2021). Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital. International Journal of Infectious Diseases, 105, 532–539. https://doi.org/10.1016/j.ijid.2021.02.117.
Impact Factor: 12.7, Citations: 22.

Vita, S., Centanni, D., Lanini, S., Piselli, P., Rosati, S., Giancola, M., Mondi, A., Pinnetti, C., Topino, S., Chinello, P., … Nicastri, E. (2021). Benefits of steroid therapy in COVID-19 patients with different PaO2/FiO2 ratio at admission. Journal of Clinical Medicine, 10(15), 3236. https://doi.org/10.3390/jcm10153236.
Impact Factor: 4.9, Citations: 4.

Ruba Altahla | Orthopedic Rehabilitation | Best Research Article Award

Posted on 14/10/202412/11/2024 by Pencis

Dr. Ruba Altahla | Orthopedic Rehabilitation | Best Research Article Award

Dr. Ruba Altahla , Huazhong University of Science and Technology, China.

Ruba Altahla is a researcher specializing in Orthopedic Rehabilitation. She has made significant contributions to the field through her studies on rehabilitation techniques aimed at improving patient outcomes after orthopedic surgeries. Her research focuses on developing innovative, evidence-based approaches to restore mobility and functionality in patients with musculoskeletal injuries.

Profile:

Scopus Profile

Education

Dr. Ruba Altahla earned her Master’s degree in Physical Therapy and Rehabilitation Medicine from the Medical College at Huazhong University of Science and Technology, Tongji, in 2021. Prior to that, she completed a one-year diploma in Chinese language at the same institution in 2017. Dr. Altahla holds a Bachelor’s degree in Physiotherapy, which she obtained from Al-Baath University, Faculty of Health Science, in 2012.

Experience

Dr. Ruba Altahla has extensive clinical experience in physiotherapy and rehabilitation medicine. She completed her clinical training at Wuhan Tongji Hospital from September 2018 to 2021. Prior to that, she volunteered as a home-based care physical therapist with Mawadah Community Center and Al Baer Social Association, both funded by UNHCR, from June 2016 to July 2017. In addition to her clinical work, Dr. Altahla has teaching experience at Al-Baath University, where she supervised practical sessions for courses including Physiology of the Neurological and Muscular Systems, Rehabilitation for Amputees, Electrotherapy, and Rehabilitation of Joint Diseases between 2013 and 2017. She also supervised practical sections in the Department of Chemistry during the 2013-2014 academic year. Dr. Altahla has attended several courses and conferences, including the International Computer Driving License (ICDL), an English language course, and international courses in physiotherapy and occupational therapy. She also completed a Clinical Applications of Epidemiology course in July 2021.

Top Note Publications

Article: Thioredoxin-Interacting Protein’s Role in NLRP3 Activation and Osteoarthritis Pathogenesis by Pyroptosis Pathway: In Vivo Study
Author: Altahla, R., & Xu, T.
Journal: Metabolites
Year: 2024

Article: Ferroptosis plays a role in osteoarthritis
Author: Altahla, R., Alshorman, J., & Xu, T.
Journal: All Life
Year: 2024

Article: A cross-sectional survey on the effects of the COVID-19 pandemic on psychological well-being and quality of life in people with spinal cord injury
Author: Altahla, R., Alshorman, J., Ali, I., & Xu, T.
Journal: Journal of Orthopaedic Surgery and Research
Year: 2024

Article: The impact of COVID-19 on epidemiological features of spinal cord injury in Wuhan, China: a comparative study in different time periods
Author: Altahla, R., Alshorman, J., & Xu, T.
Journal: Medicina
Year: 2023

Article: Epidemiological characteristics: traumatic cervical spinal cord injury in Wuhan-China
Author: Altahla, R., Alshorman, J., & Xu, T.
Journal: Academia Medicine
Year: 2024

Article: Guidelines for treating spinal cord injury without radiological abnormalities in children
Author: Altahla, R., Alshorman, J., & Xu, T.
Journal: INNOSC Theranostics and Pharmacological Sciences
Year: 2023

Article: Prevalence of Musculoskeletal Disorders and Associated Work-related Risk Factors in Chinese Physiotherapists: A Comparative Study
Author: Altahla, R., Alshorman, J., & Xu, T.
Journal: ALANBAR Medical Journal
Year: 2024

Article: Recommendations on the management and prevention of spinal cord injury in children following backbend dance
Author: Alshorman, J., Altahla, R., & Xu, T.
Journal: INNOSC Theranostics and Pharmacological Sciences
Year: 2024

Reigner Jay Escartin | HIV-1 | Best Researcher Award-duplicate-1

Posted on 09/10/2024 by Pencis

Reigner Jay Escartin | HIV-1 | Best Researcher Award

Mr. Reigner Jay Escartin , University of the Immaculate Conception, Philippines.

Mr. Reigner Jay Escartin is an accomplished researcher specializing in HIV-1 studies. His groundbreaking work has significantly advanced the understanding of the virus, focusing on treatment strategies and viral pathogenesis. His dedication to HIV research has earned him the prestigious Best Researcher Award, recognizing his contributions to global health and scientific innovation. Escartin’s research continues to impact the fight against HIV/AIDS, with a commitment to improving patient outcomes and advancing therapeutic approaches.

Profile:

Orcid Profile

Education and Experience

Mr. Reigner Jay Escartin holds a Bachelor of Science in Medical Technology/Medical Laboratory Science from the University of the Immaculate Conception. He completed his Medical Technology internship at Davao Doctors Hospital (2022–2023) and is currently pursuing a Master of Science in Medical Technology, majoring in Biomedical Sciences (2023–present). Mr. Escartin serves as a full-time faculty member and clinical instructor at his alma mater. He is a registered member of PAMET, PAPSI, and the Philippine Association of Schools of Medical Technology and Public Health, Inc. Additionally, he holds a Lean Six Sigma White Belt certification, reflecting his commitment to continuous improvement in the field.

Areas of Research

Mr. Reigner Jay Escartin’s primary research area focuses on HIV-1, with a notable contribution to understanding the success rates and adherence to antiretroviral therapy (ART) among treatment-naïve patients in Davao City, Philippines. His work is highlighted by a ten-year retrospective cohort study that examined the long-term effectiveness of ART, analyzing patient adherence and identifying key factors that influence treatment outcomes. Through this research, Mr. Escartin has contributed valuable insights into the challenges faced by HIV-1 patients in adhering to therapy, particularly within local contexts. His findings aim to improve healthcare delivery and patient support systems, ultimately enhancing the quality of life for individuals living with HIV. Although still early in his career, his commitment to research and innovation in HIV-1 therapy provides a foundation for future development and collaboration in both clinical and public health settings. By addressing real-world issues in HIV treatment, his work is poised to drive further research and extension activities that could have a lasting impact on patient care and treatment protocols in the region.

Research and Innovations

Mr. Reigner Jay Escartin has completed one ongoing research project, though he currently has no consultancy or industry-sponsored projects, and the total cost of his projects is not applicable. He has published one journal article indexed in Scopus, Web of Science, or PubMed, but has no publications in SCI or SCIE indexes. He has not yet published any books, chapters, or conference proceedings, nor has he filed any patents. Additionally, he holds no editorial appointments in journals or conferences and has no citation index, H-index, or cumulative impact factor in the past three years. He has not presented at conferences, served as an invited speaker or resource person, or organized any research conferences or workshops. Mr. Escartin has not visited other countries for research, has not graduated any research scholars, and has no ongoing scholars under his supervision. He is also not involved in collaborative research activities, holds no awards or recognitions, and has not established functional MoUs with other institutions or industries. Lastly, he is not a member of any professional bodies.

Top Note Publications

Escartin, R. J. (2024, December). Success rates and adherence to antiretroviral therapy among treatment-naïve patients in Davao City, Philippines: A ten-year retrospective cohort study. Dialogues in Health, ISSN 2772-6533. https://doi.org/10.1016/j.dialog.2024.100195

Reigner Jay Escartin | HIV-1 | Best Researcher Award

Posted on 07/10/202407/10/2024 by Pencis

Reigner Jay Escartin | HIV-1 | Best Researcher Award